What are you searching for?

02.11.2020 | Tracker

Top 50 Pharma Tracker: Regeneron tops list due to high profile COVID-19 treatment conversation

By Mary Kangley

Discover what healthcare professionals (HCPs) think about pharmaceutical products and their manufacturers, as it happens, through CREATION.co’s tracking updates. How are HCPs responding to drug launch news? How are HCPs talking about or engaging with the Top 50 pharma companies on social media? Each week CREATION.co’s tracking updates bring you the latest insights from the conversation of HCPs across the globe discussing these topics and more.

October’s Top 50 Pharmaceutical Companies mentioned by HCPs on Twitter, in relation to COVID-19

November
Rank
October
Rank
Company
Name
Total
Mentions
Account
Mentions
Account
Retweets
14Pfizer29,7465,194498
25AstraZeneca4,9581,21075
32JohnsonandJohnson1,473705127
46GSK91028257
53Gilead7862066
69Sanofi72232589
71Regeneron67610214
87Lilly58918711
912MerckandCo524393158
1011Novartis46336861
118Roche43821067
1210Abbott4193609
1314AbbVie39536615
1424Biogen347491
1513Bayer33618316
1619NovoNordisk23018746
1715Amgen17213316
1816Boehringer15813945
1921Servier1201061
2022Takeda1049733
2117BMS1007424
2233Ipsen755913
2318Fresenius695425
2420UCB676147
2523Teva555030
2626MerckKGaA524511
2725Allergan4430
2835CSL39373
2931Mylan36153
3029Menarini333017
3128Otsuka3063
3232Chugai3000
3330DaiichiSankyo26144
3439Astellas26190
3538Alexion25122
3636Bausch2141
3737Eisai1881
3834Grifols1620
3927Vertex12110
4040Sun1042
5050MitsubishiTanabePharma000
5050JiangsuHengrui000
5050Ono000
5050Endo000
5050Meiji000
5050Yunnan Baiyao000
5050Aurobindo000
5050Sino000
5050Shanghai000
5050SumitomoDainippon000

October’s insights from HCPs mentioning the Top 50 Pharmaceutical Companies, in relation to COVID-19

The five pharmaceutical companies that were mentioned the most by healthcare professionals (HCPs) on Twitter during October 2020 were Regeneron, Johnson and Johnson (J&J), Gilead, Pfizer, and AstraZeneca.

Top 50 Pharma discussed online

For the first time since CREATION.co began tracking in August 2019, Regeneron not only entered the top 5 list, but was the most mentioned pharmaceutical company by HCPs overall. This was due to the endorsement of their experimental monoclonal antibody cocktail for the treatment of COVID-19 by Donald Trump. This came after the outgoing US President tested positive for the virus and was treated with the drugs under a compassionate use request. HCPs responded to Trump’s comments by reminding their networks that the treatment is not yet approved or available for public use.

As well as this story, HCPs shared links to reports of more of the latest news in COVID-19 treatment.

  1. The most shared link from HCPs was the STAT News story that the J&J Covid-19 vaccine study had to be paused due to an unexplained illness in participant.
  2. HCPs also shared Science Mag’s report of the ‘very, very bad look’ of remdesivir, the first FDA-approved COVID-19 drug.
  3. They also posted from CNN Business who stated that Trump has ties to Regeneron and now its stock is surging.

HCPs disseminated information about J&J’s Phase III COVID-19 vaccine candidate trial being paused. This comes after AstraZeneca’s trial with the University of Oxford was also put on hold last month over safety concerns.

Top 50 Pharma discussed online

COVID-19 discussion increased by 217% from last month, making up over 56% of the overall conversation about top 50 pharmaceutical companies. Despite no significant spikes in the conversation outside of those relating to COVID-19, HCPs continued to share good news from pharmaceutical companies including successful trials and product approvals.

 

CREATION.co continues to analyse online HCP conversation on a variety of topics including virtual congress, healthcare changes since the pandemic, product development and therapy area specific insights.

To stay up to date, you can sign up to CREATION.co’s monthly eJournal.

 

  • In October 2020, CREATION Pinpoint® identified 25,286 healthcare professional (HCP) authored tweets from 10,478 individual HCPs mentioning a top-50 pharmaceutical company (according to revenue). 
  • Data for this research was analysed from the online Twitter conversations of HCPs in all languages mentioning a Top 50 pharmaceutical company between October 1st and October 31st 2020.
  • Unless otherwise specified, mentions of a company are not limited to its Twitter account(s).
  • In some cases, a tweet may mention more than one company account (eg. @abbottnews and @abbottglobal) – this only counts as one Company Mention but two Account Mentions.
  •  Johnson & Johnson was included as a whole, encompassing its pharmaceutical subsidiary, Janssen. In October, 649 of these posts mentioned Janssen

The Top 50 Pharma tracker archive

View all articles >

Meet the Author

Mary Kangley

As a Health Insights Consultant Mary is passionate about telling stories with data from online healthcare conversations. Her work is guided by a background in human and cyber-psychology providing a curiosity to understand what HCPs think. As a keen music fan, Mary’s greatest pride is her Spotify playlists that are continually growing as she makes new discoveries.

Suggested next


06.02.2020 | Article

Top 50 Pharma Tracker: New year begins with failed trials and successful podcast launch

Top 50 Pharma Tracker: New year begins with failed trials and successful podcast launch

By Mary Kangley

22.02.2021 | Article

UK HCPs call for roll out of Respiratory Support Units at virtual BTS Winter Meeting

Discover what healthcare professionals (HCPs) think about respiratory disease

By Laura Marsh

View all articles >